2004
Parasitological resistance of Plasmodium falciparum to antimalarial drugs: what physicians should keep in mind.
Tinto H, Ouédraogo J, Traoré M, Guiguemdé T. Parasitological resistance of Plasmodium falciparum to antimalarial drugs: what physicians should keep in mind. Cahiers De Santé 2004, 14: 69-73. PMID: 15454363.Peer-Reviewed Original ResearchConceptsMalaria case managementParasitological resistanceAntimalarial drugsCase managementDrug resistancePlasmodium falciparum drug resistanceSemi-immune subjectsNon-immune subjectsMalaria drug resistanceAttitudes of physiciansSelective drug pressurePublic health practiceTherapeutic decisionsDrug pressureHost immunityParasitological resultsHealth practicesClinical levelPlasmodium falciparumResistant strainsPhysiciansDrugsLower proportionVivoClassification system
2002
Chloroquine and sulphadoxine‐pyrimethamine efficacy for uncomplicated malaria treatment and haematological recovery in children in Bobo‐Dioulasso, Burkina Faso during a 3‐year period 1998–2000
Tinto H, Zoungrana E, Coulibaly S, Ouedraogo J, Traoré M, Guiguemde T, Van Marck E, D'Alessandro U. Chloroquine and sulphadoxine‐pyrimethamine efficacy for uncomplicated malaria treatment and haematological recovery in children in Bobo‐Dioulasso, Burkina Faso during a 3‐year period 1998–2000. Tropical Medicine And International Health 2002, 7: 925-930. PMID: 12390597, DOI: 10.1046/j.1365-3156.2002.00952.x.Peer-Reviewed Original ResearchConceptsPrevalence of anemiaClinical failureParasitological resistancePacked cell volumeUncomplicated malariaDay 14Day 0Uncomplicated malaria treatmentHaematological recoveryMalaria treatmentCQ resistanceHealth centersRegular surveillanceAntimalarial drugsChloroquineBurkina FasoPrevalenceBobo-DioulassoChildrenAnemiaEvidence of increasesMalariaTreatmentFailureCell volume